Correspondence to the Lancet two weeks ago revealed another instance in which clinical research studies that failed to provide results favorable to a sponsor's product were suppressed.
[Tfeft-Hansen PC. Unpublished clinical trials of sumatriptan. Lancet 2009; 374: 1501-2. Link here .]
Sumatriptan, sold as Imitrex by GlaxoSmithKline, and now available generically, is a commonly used treatment for acute migraine headaches. A Cochrane review from 2003 concluded that multiple clinical trials versus placebo showed that the drug is a...
Post new comment